Skip to content

Public FDA record

Z-0820-2018: Truth Renew

Recall record Z-0820-2018 for Accord Media, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0820-2018
Company in FDA record
Accord Media, LLC
FDA record creation date
Mar 1, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Distribution of medical devices with unapproved green LED light used to treat hyperpigmentation

Source facts

Action
On December 4, 2017, Accord Media distributed Urgent Medical Device Field Action notices and Response Forms to customers via courier service. Customers were instructed to inspect stock and identify affected product whereby the would apply a label to the product which reads "DO NOT USE GREEN LIGHT FUNCTIONALITY - NOT FDA CLEARED FOR USE". Customers are encouraged to complete and return the response form via email to: customerservice@truthinaging.com.
Initiated
2017-12-04
Root cause
Device Design
Terminated
2020-05-28
Distribution
US Nationwide
Recall number
Z-0820-2018
Recall status
Terminated
CDRH record ID
161786
FDA record created
2018-03-01
Recall event number
79262

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗